Importantly, the truncated tMMP8 embedded into the HBV part of the chimeric Ad-HBV vector maintained key therapeutic features previously seen with conventional Ad vector delivery of full-length MMP-8 [33], [38], namely a similarly efficient reduction of fibrosis and cirrhosis, and in addition the activation of signals promoting hepatocyte proliferation. This evidence concerns the gene MMP8 and fibrosis.